Across TCGA pan-cancer cohorts, CYCSP52 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated CYCSP52 data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CYCSP52 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CYCSP52 expression acts as an unfavorable survival marker, although some lineages such as BRCA and STAD show a favorable association.
KIRP, LGG, and BRCA are the cancer types where CYCSP52 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.